Literature DB >> 22624713

Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.

Keli Xu1, Jerry Usary2, Philaretos C Kousis1, Aleix Prat2, Dong-Yu Wang3, Jessica R Adams4, Wei Wang1, Amanda J Loch1, Tao Deng5, Wei Zhao2, Robert Darrell Cardiff6, Keejung Yoon7, Nicholas Gaiano7, Vicki Ling8, Joseph Beyene9, Eldad Zacksenhaus5, Tom Gridley10, Wey L Leong3, Cynthia J Guidos11, Charles M Perou2, Sean E Egan12.   

Abstract

Basal-like breast cancers (BLBC) express a luminal progenitor gene signature. Notch receptor signaling promotes luminal cell fate specification in the mammary gland, while suppressing stem cell self-renewal. Here we show that deletion of Lfng, a sugar transferase that prevents Notch activation by Jagged ligands, enhances stem/progenitor cell proliferation. Mammary-specific deletion of Lfng induces basal-like and claudin-low tumors with accumulation of Notch intracellular domain fragments, increased expression of proliferation-associated Notch targets, amplification of the Met/Caveolin locus, and elevated Met and Igf-1R signaling. Human BL breast tumors, commonly associated with JAGGED expression, elevated MET signaling, and CAVEOLIN accumulation, express low levels of LFNG. Thus, reduced LFNG expression facilitates JAG/NOTCH luminal progenitor signaling and cooperates with MET/CAVEOLIN basal-type signaling to promote BLBC.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624713      PMCID: PMC3603366          DOI: 10.1016/j.ccr.2012.03.041

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  83 in total

1.  Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.

Authors:  Toula Bouras; Bhupinder Pal; François Vaillant; Gwyndolen Harburg; Marie-Liesse Asselin-Labat; Samantha R Oakes; Geoffrey J Lindeman; Jane E Visvader
Journal:  Cell Stem Cell       Date:  2008-10-09       Impact factor: 24.633

2.  Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.

Authors:  Connie W Lee; Christopher M Raskett; Igor Prudovsky; Dario C Altieri
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

3.  Transcriptome analysis of the normal human mammary cell commitment and differentiation process.

Authors:  Afshin Raouf; Yun Zhao; Karen To; John Stingl; Allen Delaney; Mary Barbara; Norman Iscove; Steven Jones; Steven McKinney; Joanne Emerman; Samuel Aparicio; Marco Marra; Connie Eaves
Journal:  Cell Stem Cell       Date:  2008-07-03       Impact factor: 24.633

4.  JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.

Authors:  Michael Reedijk; Dushanthi Pinnaduwage; Brendan C Dickson; Anna Marie Mulligan; Hui Zhang; Shelley B Bull; Frances P O'Malley; Sean E Egan; Irene L Andrulis
Journal:  Breast Cancer Res Treat       Date:  2007-11-08       Impact factor: 4.872

5.  A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR.

Authors:  Elizabeth Monaghan-Benson; Cynthia Corley Mastick; Paula J McKeown-Longo
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

6.  ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.

Authors:  C Osipo; P Patel; P Rizzo; A G Clementz; L Hao; T E Golde; L Miele
Journal:  Oncogene       Date:  2008-05-12       Impact factor: 9.867

7.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

Review 8.  Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance.

Authors:  Shunzo Kobayashi
Journal:  Breast Cancer       Date:  2008-03-01       Impact factor: 4.239

Review 9.  Basal-like breast cancer: a critical review.

Authors:  Emad A Rakha; Jorge S Reis-Filho; Ian O Ellis
Journal:  J Clin Oncol       Date:  2008-05-20       Impact factor: 44.544

10.  Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.

Authors:  S E Elsheikh; A R Green; E A Rakha; R M Samaka; A A Ammar; D Powe; J S Reis-Filho; I O Ellis
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

View more
  59 in total

1.  Deciphering the Fringe-Mediated Notch Code: Identification of Activating and Inhibiting Sites Allowing Discrimination between Ligands.

Authors:  Shinako Kakuda; Robert S Haltiwanger
Journal:  Dev Cell       Date:  2017-01-12       Impact factor: 12.270

Review 2.  Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis.

Authors:  M U J Oliphant; Deguang Kong; Hengbo Zhou; M T Lewis; H L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-04-22       Impact factor: 2.673

3.  Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.

Authors:  S Zhang; W-C Chung; K Xu
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

4.  Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.

Authors:  Sneha Sundaram; Alex J Freemerman; Amy R Johnson; J Justin Milner; Kirk K McNaughton; Joseph A Galanko; Katharine M Bendt; David B Darr; Charles M Perou; Melissa A Troester; Liza Makowski
Journal:  Breast Cancer Res Treat       Date:  2013-11-12       Impact factor: 4.872

5.  Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision.

Authors:  Marcelo Boareto; Mohit Kumar Jolly; Eshel Ben-Jacob; José N Onuchic
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-07       Impact factor: 11.205

6.  p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.

Authors:  Jieun Yun; Ingrid Espinoza; Antonio Pannuti; Damian Romero; Luis Martinez; Mary Caskey; Adina Stanculescu; Maurizio Bocchetta; Paola Rizzo; Vimla Band; Hamid Band; Hwan Mook Kim; Song-Kyu Park; Keon Wook Kang; Maria Laura Avantaggiati; Christian R Gomez; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

7.  Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression.

Authors:  Hidetaka Ohnuki; Kan Jiang; Dunrui Wang; Ombretta Salvucci; Hyeongil Kwak; David Sánchez-Martín; Dragan Maric; Giovanna Tosato
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

8.  Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer.

Authors:  Shubing Zhang; Wen-cheng Chung; Lucio Miele; Keli Xu
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

Review 9.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

10.  Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.

Authors:  He Zhu; Feriyl Bhaijee; Nivin Ishaq; Dominique J Pepper; Kandis Backus; Alexandra S Brown; Xinchun Zhou; Lucio Miele
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.